AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Celyad Oncology SA Clinical-stage biotech developing CAR T therapies for solid and blood cancers.	Belgium	CYAD
CENTAUR MEDIA PLC Provides business intelligence, learning, and consultancy for marketing & legal professionals.	United Kingdom	CAU
Century Therapeutics, Inc. Developing iPSC-derived, off-the-shelf cell therapies for cancer & autoimmune diseases.	United States of America	IPSC
Cereno Scientific AB Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.	Sweden	CRNO
CERES INC. Develops online media platforms connecting consumers with advertisers through a rewards system.	Japan	3696
Certara, Inc. Accelerating new medicines with biosimulation software and services for pharma & biotech.	United States of America	CERT
CEVA INC Licensor of DSP, AI, wireless, and sensing IP for low-power, smart edge devices.	United States of America	CEVA
Chabiotech Co.,Ltd. Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.	South Korea	085660
Chai Communication Co., LTD. An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.	South Korea	351870
CHAMPIONS ONCOLOGY, INC. Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.	United States of America	CSBR